The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report.

MLA

Santti, Kirsi, et al. “The CDK 4/6 Inhibitor Ribociclib Has Activity in the Treatment of Inoperable Desmoid Tumor. A Case Report.” Acta Oncologica (Stockholm, Sweden), vol. 58, no. 6, June 2019, pp. 897–900. EBSCOhost, https://doi.org/10.1080/0284186X.2019.1588992.

APA

Santti, K., Beule, A., Rönty, M., Ihalainen, H., Tarkkanen, M., & Blomqvist, C. (2019). The CDK 4/6 inhibitor ribociclib has activity in the treatment of inoperable desmoid tumor. A case report. Acta Oncologica (Stockholm, Sweden), 58(6), 897–900. https://doi.org/10.1080/0284186X.2019.1588992

Chicago

Santti, Kirsi, Annette Beule, Mikko Rönty, Hanna Ihalainen, Maija Tarkkanen, and Carl Blomqvist. 2019. “The CDK 4/6 Inhibitor Ribociclib Has Activity in the Treatment of Inoperable Desmoid Tumor. A Case Report.” Acta Oncologica (Stockholm, Sweden) 58 (6): 897–900. doi:10.1080/0284186X.2019.1588992.